Painful bladder syndrome or interstitial cystitis is a chronic inflammatory disease of the bladder that causes pain, pressure, or burning in the bladder, often accompanied by urgency and increased urinary frequency.
The pain usually intensifies as the bladder fills and is partially relieved after urination, and it can persist over time, significantly affecting quality of life.
In many patients, this condition is associated with functional alterations of the pelvic floor, which can contribute to perpetuating pain and urinary symptoms, so its evaluation is part of a comprehensive and specialized approach.
Common cystitis or urinary tract infection is usually caused by bacteria and responds to antibiotic treatment. Interstitial cystitis or painful bladder syndrome is not caused by an infection; it is a chronic, autoimmune disease characterized by pelvic pain associated with bladder filling that is relieved by urination and is often associated with persistent urinary urgency and frequency.
Yes. It is often initially confused with a urinary tract infection, as both can cause pain, burning when urinating, urgency, and increased urinary frequency. However, in interstitial cystitis or painful bladder syndrome, urine cultures are usually negative, as it is not caused by bacteria. When symptoms persist despite receiving antibiotics, this possibility should be considered.
Yes. Because it can be confused with recurrent urinary tract infections or other pelvic disorders, some patients take months or even years to receive an accurate diagnosis. A specialized urology assessment allows for the study to be correctly guided and avoids unnecessary repeated treatments.
Painful bladder syndrome or interstitial cystitis is a chronic condition. This means that it can affect patients for years, although its progression varies greatly. Some people have mild and sporadic symptoms, while others may experience more persistent discomfort. With a proper diagnosis and personalized treatment, it is possible to significantly improve quality of life and reduce the intensity and frequency of symptoms.
Current management of stage T1 renal cell carcinoma in Spain: Results of a multicenter national registry.